Atlas Trials

A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia

Clinical trial NCT00171093 · COMPLETED

Trial details

NCT number
NCT00171093
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HYPERTENSIONHYPERCHOLESTEROLEMIA
Start date
2004-09-01
Primary completion
2006-01-01
Enrollment
369

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.